All News

Conjugate Vaccines Market Development Strategies, Newer Technology, Upcoming Trends and Global Industry Analysis 2020 – 2023

Conjugate Vaccine Market size is expected to hit a healthy CAGR of 10.5% during the forecast period 2017-2023.

Conjugate Vaccines Market Competitive Growth Analysis By Type (Haemophilus B, Monovalent, Multivalent, And Others), By Indication (Influenza, Pneumococcal, Meningococcal, And Others) By Regional Scope, Industry Size, Growth Dynamics, Share and Trends – Future Global Forecast Till 2023.

Global Conjugate Vaccine Market size is expected to hit a healthy CAGR of 10.5% during the forecast period 2017-2023.

Request for a FREE [email protected]

Market Overview

Conjugate vaccines are vaccines for infectious diseases. There are special polysaccharide coatings on some bacteria and viruses that help them to escape the immune system. An immature immune system can recognize these bacteria with the help of the conjugate vaccines, as these vaccines link the special polysaccharide coatings to an organism by producing immunity and response.

Global Conjugate vaccines Market Key Players:

Some of the top key players in this market are listed as Follows,

Pfizer (U.S)

Sinovac Biotech Ltd. (China)

IDT Biologics GmbH

GlaxoSmithKline plc. Merck & Co. Inc. (U.S)

Fablife. (India)

SutroVax Inc. (U.S)

Sanofi Pasteur SA.(France)

Bavarian Nordic(U.S).

GreenSignal Bio Pharma Limited (India)

Taj Pharmaceuticals Limited (India)

And Others.

The global Conjugate vaccine is segmented on the basis of type, indication, and end users.

On the basis type it is segmented into,

Haemophilus B




On the basis of indication, it is segmented into,





On the basis of end users, it is segmented into



Major factors driving growth of this market include increasing use of conjugate vaccines for adults, rising number of regulatory approvals for conjugate vaccines, rising prevalence of diseases, and technological advancements.

Browse Full Report [email protected]

Regional Analysis of the Global Conjugate vaccines Market

On the regional basis, the market is segmented into America, Europe, Asia Pacific and the Middle East & Africa. America dominates the largest market due to a significant use of the vaccine for preventing diseases and favorable conditions for research and development.

Europe is the second largest Conjugate Vaccines market in the globe followed by Asia Pacific. In Europe availability of funds for research and development activities and growing emphasis on research for prevention measures of diseases is increasing. Whereas, Asia Pacific shows the fastest growth in this market due to the increasing prevalence of communicable diseases. Developing countries in this region are emphasizing research on diseases caused to children’s and preventive measures for treating them. Mainly, India and China are expected to be an emerging and the fastest growing market due to the increasing population and prevalence of diseases.

The Middle East & Africa owns the lowest market in the global conjugate vaccines market due to less availability medical facilities.


1 Report Prologue

2 Market Introduction

3 Research Methodology

4 Market Dynamics

5 Market Factor Analysis

  1. Global Conjugates Vaccines Market, By Type

6.1 Haemophilus B

6.2 Monovalent

6.3 Multivalent

6.4 Others

  1. Global Conjugates Vaccines Market, By Indication

7.1 Influenza

7.2 Pneumococcal

7.3 Meningococcal

7.4 Others

  1. Global Conjugates Vaccines Market, By End User

8.1 Pediatrics

8.2 Adults


Ask for any query Or Help on


Market Research Future

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: [email protected]

Back to top button